Also trades as: DHR-PA (NYSE) · $vol 45M · DHR-PB (NYSE) · $vol 16M · 0R2B.L (LSE) · $vol 2M · DAP.DE (XETRA) · $vol 0M
DHR NYSE
Danaher Corporation
1W: +3.8%
1M: +4.0%
3M: +17.2%
YTD: +1.7%
1Y: +5.4%
3Y: +14.4%
5Y: -11.4%
$232.09
-0.88 (-0.38%)
After Hours: $232.00 (-0.09, -0.04%)
Weekly Expected Move ±4.7%
$209
$220
$230
$241
$252
Credit Risk of going bust: lower than 77% of companies Debt: 13.9% of company value Bonds: $108.9M held by 148 funds, 71 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.66 (down 99%), Danaher Corporation would be worth roughly what it owes.
Total debt $26.48B against a stock market value of $163.77B.
Distance to default 9.04 (Merton model): prices to 2026-10-26, balance sheet 2026-09-25, debt counted $14.29B (short-term plus half of long-term), stock volatility 30.2%; Altman Z'' 3.91. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.66 (down 99%), Danaher Corporation would be worth roughly what it owes.
Total debt $26.48B against a stock market value of $163.77B.
Distance to default 9.04 (Merton model): prices to 2026-10-26, balance sheet 2026-09-25, debt counted $14.29B (short-term plus half of long-term), stock volatility 30.2%; Altman Z'' 3.91. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$26B
Revenue
+5.5% YoY
$4B
Net Income
+23.6% YoY
$6B
Free Cash Flow
+14.2% YoY
58.5%
Gross Margin
19.0%
Op. Margin
18.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE8.3%
ROA5.0%
ROIC6.3%
Valuation
P/E37.9
P/B3.0
EV/EBITDA26.9
Leverage
Debt/Equity0.49
Current Ratio1.63
Interest Cov.35.5x
Quality Scores
Piotroski F7/9
Altman Z3.67
Beneish M-2.27